$70.50
-0.37 (-0.5%)
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$7.4B
ROE
-103.4%
D/E
0.00
Beta
1.25
52W
$12–$84
Wall Street Consensus
9 analysts · Mar 20262
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
NUVL
Nuvalent, Inc
$7.3B
KRYS
Krystal Biotech Inc
P/E 35.9
$7.1B
HALO
Halozyme Therapeutics Inc
P/E 13.3
$7.9B
IBRX
Immunitybio Inc
$2.0B
KYMR
Kymera Therapeutics Inc
$6.1B
ACLX
Arcellx Inc
$3.8B
PTGX
Protagonist Therapeutics Inc
P/E 118.9
$5.5B
RYTM
Rhythm Pharmaceuticals Inc
$7.1B
SRRK
Scholar Rock Holding Corp
$4.5B
Earnings
Beat rate: 25.0%
Next Report
May 11, 2026
EPS Estimate: $-0.93
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.93 | — | — |
| Sep 2025 | $-0.74 | $-1.11 | $-0.37 |
| Jun 2025 | $-0.67 | $-0.66 | +$0.01 |
| Mar 2025 | $-0.87 | $-1.03 | $-0.16 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -103.3% | -103.4% | -103.4% | -103.4% | -103.4% | -103.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 5.26 | 5.26 | 5.26 | 5.26 | 5.26 | 5.26 |
Key Ratios
ROA (TTM)
-68.5%
EPS (TTM)
$-3.71
52W High
$83.86
52W Low
$12.30
$12.30
52-Week Range
$83.86
How does MTSR compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
MTSR valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
MTSR profitability vs Biotechnology peers
ROE
-103.4%
▼
54%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-68.5%
▼
47%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
MTSR financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
5.3
▲
18%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
1.3
▲
28%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
MTSR fundamentals radar
MTSR
Peer median
Industry
MTSR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MTSR vs peers: key metrics
Latest News
No related news yet